share_log

中國生物製藥:董事會召開通知

SINO BIOPHARM: NOTIFICATION OF BOARD MEETING

Hong Kong Stock Exchange ·  Jul 31 04:36
Summary by Moomoo AI
中國生物製藥有限公司宣佈,將於2024年8月13日(星期二)召開董事會會議,主要目的是批准及公布截至2024年6月30日止六個月的未經審核中期業績,並將考慮是否派發中期股息。該會議將由公司秘書陳凱年執行,並於2024年7月31日在香港公告。目前,公司董事會由六位執行董事和五位獨立非執行董事組成。
中國生物製藥有限公司宣佈,將於2024年8月13日(星期二)召開董事會會議,主要目的是批准及公布截至2024年6月30日止六個月的未經審核中期業績,並將考慮是否派發中期股息。該會議將由公司秘書陳凱年執行,並於2024年7月31日在香港公告。目前,公司董事會由六位執行董事和五位獨立非執行董事組成。
Sino Biopharmaceutical Limited announced that the board of directors will hold a meeting on Tuesday, August 13, 2024 to mainly approve and disclose the unaudited interim results for the six months ended June 30, 2024, and consider whether to distribute interim dividends. The meeting will be chaired by the company secretary, Kai Nian Chen, and will be announced in Hong Kong on July 31, 2024. Currently, the board of directors of the company is composed of six executive directors and five independent non-executive directors.
Sino Biopharmaceutical Limited announced that the board of directors will hold a meeting on Tuesday, August 13, 2024 to mainly approve and disclose the unaudited interim results for the six months ended June 30, 2024, and consider whether to distribute interim dividends. The meeting will be chaired by the company secretary, Kai Nian Chen, and will be announced in Hong Kong on July 31, 2024. Currently, the board of directors of the company is composed of six executive directors and five independent non-executive directors.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more